Recipharm, a global CDMO, has developed a new, dedicated manufacturing facility in support of the latest FDA regulatory ...

China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...

India's recent Free Trade Agreement with the EU is poised to revolutionize its healthcare sector, particularly ...

QINGDAO, SHANDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- The landscape of environmental monitoring and ...